mTOR is also implicated in cognitive decline during normal aging, and Rapamycin administration has been able to preserve brain function and mitigate cognitive decline in AD by increasing autophagy and reducing amyloid-beta and tau pathogenic proteins (Kaeberlein and Galvan, 2019; Mueed et al., 2019). The gene discussed is MTOR; the disease is Alzheimer disease.